A. Ahmad, Breast Cancer statistics: recent trends. Adv. Exp. Med. Biol. 1152, 1–7 (2019)

Article  CAS  PubMed  Google Scholar 

N. Mars, S. Kerminen, M. Tamlander, M. Pirinen, E. Jakkula, K. Aaltonen, T. Meretoja, S. Heinävaara, E. WidénS. Ripatti. Comprehensive inherited risk estimation for risk-based breast Cancer screening in women. J. Clin. Oncol. JCO2300295 (2024)

M. Malvezzi, G. Carioli, P. Bertuccio, P. Boffetta, F. Levi, La VecchiaE. Negri. European cancer mortality predictions for the year 2019 with focus on breast cancer. Ann. Oncol. 30, 781–787 (2019)

Article  CAS  PubMed  Google Scholar 

Y. Liang, H. Zhang, X. SongQ, Yang. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 60, 14–27 (2020)

Article  CAS  PubMed  Google Scholar 

F. Petralia, W. Ma, T.M. Yaron, F.P. Caruso, N. Tignor, J.M. Wang, D. Charytonowicz, J.L. Johnson, E.M. Huntsman, G.B. Marino, A. Calinawan, J.E. Evangelista, M.E. Selvan, S. Chowdhury, D. Rykunov, A. Krek, X. Song, B. Turhan, K.E. Christianson, D.A. Lewis, E.Z. Deng, D.J.B. Clarke, J.R. Whiteaker, J.J. Kennedy, L. Zhao, R.L. Segura, H. Batra, M.G. Raso, E.R. Parra, R. Soundararajan, X. Tang, Y. Li, X. Yi, S. Satpathy, Y. Wang, M. Wiznerowicz, T.J. González-Robles, A. Iavarone, S.J.C. Gosline, B. Reva, A.I. Robles, A.I. Nesvizhskii, D.R. Mani, M.A. Gillette, R.J. Klein, M. Cieslik, B. Zhang, A.G. Paulovich, R. Sebra, Z.H. Gümüş, G. Hostetter, D. Fenyö, G.S. Omenn, L.C. Cantley, A. Ma’ayan, A.J. Lazar, M. CeccarelliP. Wang. Pan-cancer proteogenomics characterization of tumor immunity. Cell. 187, 1255–1277 e1227 (2024)

E.J. Brea, C.Y. Oh, E. Manchado, S. Budhu, R.S. Gejman, G. Mo, P. Mondello, J.E. Han, C.A. Jarvis, D. Ulmert, Q. Xiang, A.Y. Chang, R.J. Garippa, T. Merghoub, J.D. Wolchok, N. Rosen, LoweD.A. Scheinberg. Kinase regulation of human MHC class I molecule expression on Cancer cells. Cancer Immunol. Res. 4, 936–947 (2016)

Article  CAS  PubMed  PubMed Central  Google Scholar 

C.L. Tan, K. Lindner, T. Boschert, Z. Meng, A. Rodriguez Ehrenfried, A. De Roia, G. Haltenhof, A. Faenza, F. Imperatore, L. Bunse, J.M. Lindner, R.P. Harbottle, M. Ratliff, R. Offringa, I. Poschke, M. PlattenE.W. Green. Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy. Nat. Biotechnol. (2024)

S. Jhunjhunwala, C. HammerL, Delamarre. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat. Rev. Cancer. 21, 298–312 (2021)

Article  CAS  PubMed  Google Scholar 

K. Dhatchinamoorthy, ColbertK.L. Rock. Cancer Immune Evasion through loss of MHC Class I Antigen Presentation. Front. Immunol. 12, 636568 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

G.L. Peng, L. Li, Y.W. Guo, P. Yu, X.J. Yin, Wang C.P. Liu. CD8(+) cytotoxic and FoxP3(+) regulatory T lymphocytes serve as prognostic factors in breast cancer. Am. J. Transl Res. 11, 5039–5053 (2019)

CAS  PubMed  PubMed Central  Google Scholar 

W. Scheper, S. Kelderman, L.F. Fanchi, C. Linnemann, G. Bendle, M.A.J. de Rooij, C. Hirt, R. Mezzadra, M. Slagter, K. Dijkstra, R.J.C. Kluin, P. Snaebjornsson, K. Milne, B.H. Nelson, H. Zijlmans, G. Kenter, E.E. Voest, HaanenT.N. Schumacher. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat. Med. 25, 89–94 (2019)

Article  CAS  PubMed  Google Scholar 

Y. Wang, X. Wang, X. Cui, Y. Zhuo, H. Li, C. Ha, L. Xin, Y. Ren, W. Zhang, X. Sun, L. Ge, X. Liu, J. He, T. Zhang, K. Zhang, Z. Yao, X. YangJ. Yang. Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8(+) T cell response in tumor. Sci. Adv. 6 (2020)

C. PohlI, Dikic. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 366, 818–822 (2019)

Article  Google Scholar 

J. Park, J.C.E.J. Song, Ubiquitin-proteasome system (UPS) as a target for anticancer treatment. Arch. Pharm. Res. 43, 1144–1161 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Luza, C.M. Opazo, C.A. Bousman, C. Pantelis, BushI.P. Everall. The ubiquitin proteasome system and schizophrenia. Lancet Psychiatry. 7, 528–537 (2020)

Article  PubMed  Google Scholar 

A. Gao, Y. SunG, Peng. ILT4 functions as a potential checkpoint molecule for tumor immunotherapy. Biochim. Biophys. Acta Rev. Cancer. 1869, 278–285 (2018)

Article  CAS  PubMed  Google Scholar 

L. Singh, E.S. Muise, A. Bhattacharya, J. Grein, S. Javaid, P. Stivers, J. Zhang, Y. Qu, B. Joyce-Shaikh, A. Loboda, C. Zhang, M. Meehl, D.Y. Chiang, S.H. Ranganath, RosenzweigP.E. Brandish. ILT3 (LILRB4) promotes the immunosuppressive function of Tumor-Educated Human Monocytic myeloid-derived suppressor cells. Mol. Cancer Res. 19, 702–716 (2021)

Article  CAS  PubMed  Google Scholar 

H.M. Chen, W. van der Touw, Y.S. Wang, K. Kang, S. Mai, J. Zhang, D. Alsina-Beauchamp, J.A. Duty, S.K. Mungamuri, B. Zhang, T. Moran, R. Flavell, S. Aaronson, H.M. Hu, H. Arase, S. Ramanathan, R. Flores, PanS.H. Chen. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity. J. Clin. Invest. 128, 5647–5662 (2018)

Article  PubMed  PubMed Central  Google Scholar 

X. Kang, C. Cui, C. Wang, G. Wu, H. Chen, Z. Lu, X. Chen, L. Wang, J. Huang, H. Geng, M. Zhao, Z. Chen, M. Müschen, WangC.C. Zhang. CAMKs support development of acute myeloid leukemia. J. Hematol. Oncol. 11, 30 (2018)

Article  PubMed  PubMed Central  Google Scholar 

J. Zheng, M. Umikawa, C. Cui, J. Li, X. Chen, C. Zhang, H. Huynh, X. Kang, R. Silvany, X. Wan, J. Ye, A.P. Canto, S.H. Chen, H.Y. Wang, WardC.C. Zhang. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature. 485, 656–660 (2012)

Article  CAS  PubMed  PubMed Central  Google Scholar 

X. Liu, X. Yu, J. Xie, M. Zhan, Z. Yu, L. Xie, H. Zeng, F. Zhang, G. Chen, YiJ. Zheng. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells. Oncotarget. 6, 21004–21015 (2015)

Article  PubMed  PubMed Central  Google Scholar 

Z. Cai, L. Wang, Y. Han, W. Gao, X. Wei, R. Gong, M. Zhu, Y. SunS, Yu. Immunoglobulin–like transcript 4 and human leukocyte antigen–G interaction promotes the progression of human colorectal cancer. Int. J. Oncol. 54, 1943–1954 (2019)

CAS  PubMed  PubMed Central  Google Scholar 

H. Shao, L. Ma, F. Jin, Y. Zhou, TaoY. Teng. Immune inhibitory receptor LILRB2 is critical for the endometrial cancer progression. Biochem. Biophys. Res. Commun. 506, 243–250 (2018)

Article  CAS  PubMed  Google Scholar 

J. Liu, L. Wang, W. Gao, L. Li, X. Cui, H. Yang, W. Lin, Q. Dang, N. ZhangY, Sun. Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10. Diagn. Pathol. 9, 85 (2014)

Article  PubMed  PubMed Central  Google Scholar 

Z. Jiang, Q. Zhou, C. Ge, J. Yang, H. Li, T. Chen, H. Xie, Y. Cui, M. Shao, LiH. Tian. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma. Cancer Lett. 447, 1–11 (2019)

Article  CAS  PubMed  Google Scholar 

S. Shaid, C.H. Brandts, ServeI. Dikic. Ubiquitination and selective autophagy. Cell. Death Differ. 20, 21–30 (2013)

Article  CAS  PubMed  Google Scholar 

M.P. Wickens, S. Woo, O’MalleyJ.B. Gurdon. Expression of a chicken chromosomal ovalbumin gene injected into frog oocyte nuclei. Nature. 285, 628–634 (1980)

Article  CAS  PubMed  Google Scholar 

S. Stein, L. Henze, T. Poch, A. Carambia, T. Krech, M. Preti, F.A. Schuran, M. Reich, V. Keitel, R. Fiorotto, M. Strazzabosco, L. Fischer, J. Li, L.M. Müller, J. Wagner, N. Gagliani, J. Herkel, SchwingeC. Schramm. IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression. J. Hepatol. 74, 919–930 (2021)

Article  CAS  PubMed  Google Scholar 

B. Theivanthiran, K.S. Evans, N.C. DeVito, M. Plebanek, M. Sturdivant, L.P. Wachsmuth, A.K. Salama, Y. Kang, D. Hsu, J.M. Balko, D.B. Johnson, M. Starr, A.B. Nixon, A. HoltzhausenB.A. Hanks. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. J. Clin. Invest. 130, 2570–2586 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Deng, Z. Lu, J. Zheng, X. Wan, X. Chen, K. Hirayasu, H. Sun, Y. Lam, L. Chen, Q. Wang, C. Song, N. Huang, G.F. Gao, Y. Jiang, AraseC.C. Zhang. A motif in LILRB2 critical for Angptl2 binding and activation. Blood. 124, 924–935 (2014)

Article  CAS  PubMed  PubMed Central  Google Scholar 

E.J. SijtsP, M. Kloetzel, The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell. Mol. Life Sci. 68, 1491–1502 (2011)

Article  Google Scholar 

G. Li, L. Tang, C. Hou, Z. Wang, Y. Gao, S. Dou, R. Mo, Y. Hao, Z. Gao, Y. Li, J. Dong, J. Zhang, B. Shen, WangG. Han. Peripheral injection of Tim-3 antibody attenuates VSV Encephalitis by enhancing MHC-I presentation. Front. Immunol. 12, 667478 (2021)

Article  CAS